Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received approval for SUPRAX ® (Cefixime) Capsules 400 mg from the United States ...

Details concerning the Cefixime combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and ...

Lupin arm Lupin Pharmaceuticals Inc has received US Food and Drugs Administration (FDA) approval for its new drug application (NDA) to market and sell antibiotic Suprax (Cefixime) capsules in 400mg ...

Lupin announced it has received approval for Suprax (Cefixime) capsules 400 mg from the United States Food and Drugs Administration (FDA). The company expects to commence shipping the product in the ...

Lupin Pharmaceuticals announced that the FDA has approved Suprax (cefixime) 400mg capsules. Suprax is a 3 rd generation cephalosporin antibiotic indicated in treatment of susceptible infections, ...

Drug maker Lupin today said it has received approval from the U.S. health regulator to market its Suprax capsules, used for treating bacterial infections, in the American market. The company’s ...

Details concerning the Cefixime (IR) combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, ...

BALTIMORE — The Food and Drug Administration has approved a new dosage of an antibiotic drug made by Lupin Pharmaceuticals, Lupin said Tuesday. The Mumbai, India-based drug maker announced the ...

Lupin Ltd has informed BSE regarding a Press Release dated June 05, 2012 titled "Lupin receives FDA approval for SUPRAX (Cefixime) Capsules, 400 mg; NDA Approval to add to growing SUPRAX ...